[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344029-105":59,"doc-detail-344029-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","small-molecule-protein-assembly-modulators-with-pan-cancer-therapeutic-efficacy","Small molecule protein assembly modulators with pan-cancer therapeutic efficacy","","Small molecule protein assembly modulators are evaluated for pan-cancer therapeutic efficacy through a mechanistic and preclinical framework. Two structurally unrelated chemotypes, exemplified by PAV-617 and PAV-951, show antiviral activity in cell culture and demonstrate apparent pan-cancer cytotoxicity with reasonable pharmacokinetics. The study reports non-toxicity in non-cancer cell lines and in mice at doses achieving active drug exposure. Anti-tumour effects are validated in mouse xenografts against A549 and, for one chemotype, HT-29. Each compound targets unconventional transient, energy-dependent multi-protein complexes, altering homeostatic linkage between proliferation and apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/small-molecule-protein-assembly-modulators-with-pan-cancer-therapeutic-efficacy/344029/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/small-molecule-protein-assembly-modulators-with-pan-cancer-therapeutic-efficacy/344029.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are the key compounds studied for pan-cancer efficacy?","Question",{"text":112,"@type":113},"Two structurally unrelated small-molecule chemotypes are highlighted, represented by compounds PAV-617 and PAV-951.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence supports non-toxicity in the study?",{"text":117,"@type":113},"Non-toxicity is demonstrated in non-cancer cell lines and in mice at doses that achieve drug exposure at active concentrations.",{"name":119,"@type":110,"acceptedAnswer":120},"How do these compounds work at the molecular target level?",{"text":121,"@type":113},"They bind to different transient, energy-dependent multi-protein complexes, and treatment alters these complexes in a way that appears to remove a critical block linking uncontrolled proliferation and apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344029,1790997167,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Cite this article: Lingappa AF etal. 2024 Small molecule protein assembly modulators with pancancer therapeutic efficacy. Open Biol. 14: 240210.  \n[https://doi.org/10.1098/rsob.240210](https://doi.org/10.1098/rsob.240210)  \n[Received: 3 October 2023](Received: 3 October 2023)  \n[Accepted: 8 October 2024](Accepted: 8 October 2024)  \nSubject Areas:  \nbiochemistry, biotechnology, cellular biology  \nKeywords:  \ndrug discovery, pan-cancer therapeutics, allosteric modulator, restoration of homeostasis, multiprotein complex  \nAuthor for correspondence:  \nVishwanath R. Lingappa  \n[e-mail:](e-mail: vlingappa@prosetta.com)[ vlingappa@prosetta.com](e-mail: vlingappa@prosetta.com)  \n†Joint first authors.  \nElectronic supplementary material is available online at [https://doi.org/10.6084/](https://doi.org/10.6084/)[ ](https://doi.org/10.6084/)[m9.figshare.c.7557361](m9.figshare.c.7557361.)[.](m9.figshare.c.7557361.)  \nSmall molecule protein assembly modulators with pan-cancer therapeutic efficacy  \nAnuradha F. Lingappa1,†, Olayemi Akintunde1,†, Erin Samueli1, Connie Ewald1, Maya Michon1, Niloufar Ziari1, Ming Lu2, Shao Feng Yu1, Markus Froehlich1, Phuong Uyen Le3, Yuniel Fernandez3, Suguna Mallesh1, Jim Lin1, Anatoliy Kitaygorodskyy1, Dennis Solas1, Jonathan C. Reed4, Jaisri R. Lingappa4, Andreas Müller-Schiffmann5, Carsten Korth5, Dharma Prasad1, Aysegul Nalca6, Emily Aston7, Brad Fabbri7, Sanjeev K. Anand8, Thomas W. Campi8, Emma Petrouski1, Debendranath Dey1, David W. Andrews3, James L. Rubenstein2 and Vishwanath R. Lingappa1,2  \n1Prosetta Biosciences, San Francisco, CA, USA  \n2University of California San Francisco, San Francisco, CA, USA 3Sunnybrook Research Institute, Toronto, ON, Canada  \n4Department of Global Health, University of Washington, Seattle, WA, USA 5Institute of Neuropathology, Heinrich Heine University, Dusseldorf, Germany  \n6United States Army Medical Research Institute for Infectious Diseases, Frederick, MD, USA 7TechAccel, Overland Park, KS, USA  \n8Modulant Biosciences, Fishers, IN, USA  \n VRL, 0000-0003-0962-6571  \nTwo structurally unrelated small molecule chemotypes, represented by compounds PAV-617 and PAV-951, with antiviral activity in cell culture against Mpox virus (formerly known as monkeypox virus) and human immunodeficiency virus (HIV) respectively, were studied for anti-cancer efficacy. Each exhibited apparent pan-cancer cytotoxicity with reasonable pharmacokinetics. Non-toxicity is demonstrated in anon-cancer cell line and in mice at doses achieving drug exposure at active concentrations. Anti-tumour properties of both chemotypes were validated in mouse xenografts against A549 human lung cancer and, for one of the chemotypes, against HT-29 colorectal cancer. The targets of these compounds are unconventional: each binds to a different transient, energy-dependent multi-protein complex. Treatment with these compounds alters the target multi-protein complexes in a manner that appears to remove a block, crucial for cancer survival and progression, on a homeostatic linkage between uncontrolled proliferation and apoptosis. These compounds provide starting points for development of novel, next-generation, non-toxic, pan-cancer therapeutics.  \n1. Background  \nThe similarity of the interactions of viral infection and cancer with the healthy host has often been noted [1] . Both represent pathological processes of extremely diverse origin, that overcome the complex feedback controls of homeostasis, to the detriment of the host [2] . Both exploit natural selection as a powerful weapon to overcome host defences. Viruses have done so over deep evolutionary time through co-evolution with their hosts and through the emergence of resistance mutations in response to the selective pressure  \n© 2024 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, pr","cbCaip2vJK6QJB3j","https://ap.wps.com/l/cbCaip2vJK6QJB3j","pdf",1943498,22,"English","# Background\n## Viral infection and cancer similarities\n## Host homeostasis and feedback controls\n## Unconventional antiviral strategy and rationale for cancer applicability","[{\"question\":\"What are the key compounds studied for pan-cancer efficacy?\",\"answer\":\"Two structurally unrelated small-molecule chemotypes are highlighted, represented by compounds PAV-617 and PAV-951.\"},{\"question\":\"What evidence supports non-toxicity in the study?\",\"answer\":\"Non-toxicity is demonstrated in non-cancer cell lines and in mice at doses that achieve drug exposure at active concentrations.\"},{\"question\":\"How do these compounds work at the molecular target level?\",\"answer\":\"They bind to different transient, energy-dependent multi-protein complexes, and treatment alters these complexes in a way that appears to remove a critical block linking uncontrolled proliferation and apoptosis.\"}]","Small molecule protein assembly modulators with pan-cancer therapeutic efficacy | PDF",1790052799,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c966818b429bea3350d07ed7a7541033.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4aeaf65230428ddb39439de5cff4f925.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a4338ffca4b43497e8b3db9fc2740bb.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7902392598c21a5ce13b53159348db2f.webp",980,1385]